Risperdal. Photo: Housed via Wikimedia Commons
The Pennsylvania Supreme Court has declined to hear a Johnson & Johnson subsidiary's appeal in the first Risperdal lawsuit in Philadelphia to result in a plaintiff's verdict.
August 05, 2019 at 02:39 PM
1 minute read
The Pennsylvania Supreme Court has declined to hear the appeal of a Johnson & Johnson subsidiary that was hit with a $2.5 million verdict over the drug Risperdal’s association with gynecomastia.
The state’s justices denied allocatur in Pledger v. Janssen Pharmaceuticals on Aug. 2.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
